Insider Transactions in Q4 2021 at Ginkgo Bioworks Holdings, Inc. (DNA)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 07 2021	Reshma P. Shetty Director	SELL Bona fide gift	Indirect	200,000 -100.0%	-
Dec 07 2021	Barry Canton > 10% Shareholder	SELL Bona fide gift	Indirect	200,000 -100.0%	-
Dec 07 2021	Jason R Kelly Director	SELL Bona fide gift	Direct	150,000 -100.0%	-
Dec 06 2021	Reshma P. Shetty Director	BUY Conversion of derivative security	Indirect	200,000 +50.0%	-
Dec 06 2021	Barry Canton > 10% Shareholder	BUY Conversion of derivative security	Indirect	200,000 +50.0%	-
Dec 06 2021	Jason R Kelly Director	BUY Conversion of derivative security	Direct	150,000 +50.0%	-
Oct 01 2021	Reshma P. Shetty Director	BUY Exercise of conversion of derivative security	Indirect	25,782,354 +49.26%	-
Oct 01 2021	Reshma P. Shetty Director	BUY Exercise of conversion of derivative security	Direct	25,782,354 +49.26%	-
Oct 01 2021	Marie E. Fallon Officer	BUY Exercise of conversion of derivative security	Direct	490,805 +49.69%	-
Oct 01 2021	Barry Canton > 10% Shareholder	BUY Exercise of conversion of derivative security	Indirect	25,782,354 +49.26%	-
Oct 01 2021	Barry Canton > 10% Shareholder	BUY Exercise of conversion of derivative security	Direct	25,782,354 +49.26%	-

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Value

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

Operation

Value

Type

Receive news related to Ginkgo Bioworks Holdings, Inc.